[Effects of reading, exercise and exercise combined with reading on intraocular pressure for patients sustaining primary glaucoma (open angle) or ocular hypertension, both clinically controlled with topic medication].
OBJECTIVE
To check intraocular pressure (IOP) in individuals using prostaglandin, prostamide or beta-blocker analogues, who sustain either primary open angle glaucoma or ocular hypertension after reading, exercise or exercise combined with reading.


METHODS
40 individuals (79 eyes), subdivided in to five groups: G1 (with arterial hypertension and either glaucoma or ocular hypertension, all users of prostaglandin or prostamide analogues); G2 (with arterial hypertension and either glaucoma or ocular hypertension, all users of beta-blockers); G3 (not sustaining arterial hypertension but suffering from either glaucoma or ocular hypertension, all users of prostaglandin or prostamide analogues); G4 (not sustaining arterial hypertension but suffering from either glaucoma or ocular hypertension, all users of beta-blockers) and G5 (not sustaining arterial hypertension and also not suffering from either glaucoma or ocular hypertension) had their intraocular pressure checked before and after undergoing reading, exercise, and exercise combined with reading. Each type of test was conducted in a different day, always in the afternoon.


RESULTS
No significant statistical difference has been noticed between the initial and final intraocular pressure mean in the different groups, when reading, performing exercises or exercises combined with reading.


CONCLUSIONS
To read and to work out--either separately or jointly--does not pose an aggravating factor to the intraocular pressure of patients with primary open glaucoma or ocular hypertension, using prostaglandin, prostamide or beta-blocker analogues.
Medina
Alice Maria Corrêa
AM
Universidade de Brasília, Brasília, DF, CEP 70867-110 Brazil.
Lima
Núbia Vanessa dos Anjos
NV
Santos
Regina Cândida Ribeiro dos
RC
Pereira
Marco César Araújo
MC
Santos
Procópio Miguel dos
PM
D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D011932:Reading; D014065:Tonometry, Ocular
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D009883:Ophthalmic Solutions